HER2-positive male breast cancer: an update

Por Ottini, Laura, Capalbo, Carlo, Rizzolo, Piera, Silvestri, Valentina, Bronte, Giuseppe, Rizzo, Sergio, Russo, Antonio
Publicado em 2010

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

Por Incorvaia, Lorena, Bronte, Giuseppe, Bazan, Viviana, Badalamenti, Giuseppe, Rizzo, Sergio, Pantuso, Gianni, Natoli, Clara, Russo, Antonio
Publicado no Oncotarget (2016)

Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange

Por Rizzo, Claudia, Rizzo, Sergio, Scirè, Elisabetta, Di Bona, Danilo, Ingrassia, Carlo, Franco, Giovanni, Bono, Roberto, Quintini, Gerlando, Caruso, Calogero
Publicado em 2012

Nintedanib in NSCLC: evidence to date and place in therapy

Por Bronte, Giuseppe, Passiglia, Francesco, Galvano, Antonio, Barraco, Nadia, Listì, Angela, Castiglia, Marta, Rizzo, Sergio, Fiorentino, Eugenio, Bazan, Viviana, Russo, Antonio
Publicado no Ther Adv Med Oncol (2016)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Por Passiglia, Francesco, Bronte, Giuseppe, Bazan, Viviana, Natoli, Clara, Rizzo, Sergio, Galvano, Antonio, Listì, Angela, Cicero, Giuseppe, Rolfo, Christian, Santini, Daniele, Russo, Antonio
Publicado no Oncotarget (2016)

Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?

Por Fanale, Daniele, Amodeo, Valeria, Bazan, Viviana, Insalaco, Lavinia, Incorvaia, Lorena, Barraco, Nadia, Castiglia, Marta, Rizzo, Sergio, Santini, Daniele, Giordano, Antonio, Castorina, Sergio, Russo, Antonio
Publicado no Oncotarget (2016)

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway

Por Massihnia, Daniela, Galvano, Antonio, Fanale, Daniele, Perez, Alessandro, Castiglia, Marta, Incorvaia, Lorena, Listì, Angela, Rizzo, Sergio, Cicero, Giuseppe, Bazan, Viviana, Castorina, Sergio, Russo, Antonio
Publicado no Oncotarget (2016)

Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

Por Vincenzi, Bruno, Santini, Daniele, Russo, Antonio, Addeo, Raffaele, Giuliani, Francesco, Montella, Liliana, Rizzo, Sergio, Venditti, Olga, Frezza, Anna Maria, Caraglia, Michele, Colucci, Giuseppe, Del Prete, Salvatore, Tonini, Giuseppe
Publicado em 2010

Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome

Por Caramazza, Domenica, Quintini, Gerlando, Abbene, Ignazio, Coco, Lucio Lo, Malato, Alessandra, Di Trapani, Rosa, Saccullo, Giorgia, Pizzo, Giuseppina, Palazzolo, Roberto, Barone, Rita, Mazzola, Giuseppina, Rizzo, Sergio, Ragonese, Paolo, Aridon, Paolo, Abbadessa, Vincenzo, Siragusa, Sergio
Publicado em 2010

The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

Por Pantano, Francesco, Berti, Pierpaolo, Guida, Francesco Maria, Perrone, Giuseppe, Vincenzi, Bruno, Amato, Michelina Maria Carla, Righi, Daniela, Dell'Aquila, Emanuela, Graziano, Francesco, Catalano, Vincenzo, Caricato, Marco, Rizzo, Sergio, Muda, Andrea Onetti, Russo, Antonio, Tonini, Giuseppe, Santini, Daniele
Publicado em 2013

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statu...

Por Bronte, Giuseppe, Franchina, Tindara, Alù, Massimiliano, Sortino, Giovanni, Celesia, Claudia, Passiglia, Francesco, Savio, Giuseppina, Laudani, Agata, Russo, Alessandro, Picone, Antonio, Rizzo, Sergio, De Tursi, Michele, Gambale, Elisabetta, Bazan, Viviana, Natoli, Clara, Blasi, Livio, Adamo, Vincenzo, Russo, Antonio
Publicado no Oncotarget (2016)